BizReport

RSS feed Get our RSS feed

News by Topic

BizReport : White Papers : Biotechnology & Pharmaceuticals

How Pharmaceutical CFOs are Turning a Top-line Problem into a Bottom-line Success in Today's Business Climate

In an era where top-line growth is slowing due to shorter product lifecycles, growing buyer sophistication, and enhanced regulatory scrutiny, the need to reign in lost revenue and "get the numbers right" has never been greater for big and small pharmaceutical companies alike.

These pressures and market dynamics are driving pharmaceutical and biotechnology CFOs to initiate comprehensive programs to connect the disparate pieces of the revenue lifecycle. In the process, they are improving revenue and regulatory compliance through stronger pricing controls, enforcement, and enhanced revenue planning — and successfully turning a top-line problem into a bottom-line success story.

Click here to request your free White Paper!

Publisher:

Featured White Papers:

12 SEO Campaign Killers
Learn what not to do when launching a Search Engine Optimization (SEO) campaign to attract more visitors, leads and sales. >>

Social Media Marketing: 12 Essential Tips for Success
Learn how to effectively engage customer communities with a new, social marketing mix. >>


Featured Magazines:

Direct
Covers every aspect of Direct marketing, including postal and regulatory issues, creative, lists, customer relationship management and database marketing. >>

Featured Research

  • NEW! B-to-B Lead Generation Handbook
    Special $200.00 discount for BizReport readers only!
    Improve your results and the quality of your leads - download the full report right now.

http://www.bizreport.com/whitepapers/how_pharmaceutical_cfos_are_turning.html

 

 

Copyright © 1999-2008 BizReport Network. All rights reserved.
Republication or redistribution of BizReport content is expressly prohibited without the prior written consent.
BizReport shall not be liable for any errors in the content, or for any actions taken in reliance thereon.